| Prethermalization and thermalization in models with weak integrability breaking B Bertini, FHL Essler, S Groha, NJ Robinson Physical review letters 115 (18), 180601, 2015 | 180 | 2015 |
| Thermalization and light cones in a model with weak integrability breaking B Bertini, FHL Essler, S Groha, NJ Robinson Physical Review B 94 (24), 245117, 2016 | 75 | 2016 |
| Full counting statistics in the transverse field Ising chain S Groha, F Essler, P Calabrese SciPost Physics 4 (6), 043, 2018 | 45 | 2018 |
| Full counting statistics in the spin-1/2 Heisenberg XXZ chain M Collura, FHL Essler, S Groha Journal of Physics A: Mathematical and Theoretical 50 (41), 414002, 2017 | 30 | 2017 |
| Immunotherapy-Mediated Thyroid Dysfunction: Genetic Risk and Impact on Outcomes with PD-1 Blockade in Non–Small Cell Lung CancerThyroid irAEs: Genetic Risk and PD-1 Blockade … J Luo, VL Martucci, Z Quandt, S Groha, MH Murray, CM Lovly, H Rizvi, ... Clinical Cancer Research 27 (18), 5131-5140, 2021 | 12 | 2021 |
| HLA-A* 03 and response to immune checkpoint blockade in cancer: an epidemiological biomarker study V Naranbhai, M Viard, M Dean, S Groha, DA Braun, C Labaki, SA Shukla, ... The Lancet Oncology 23 (1), 172-184, 2022 | 10 | 2022 |
| A general framework for survival analysis and multi-state modelling S Groha, SM Schmon, A Gusev arXiv preprint arXiv:2006.04893, 2020 | 7* | 2020 |
| Spinon decay in the spin-1/2 Heisenberg chain with weak next nearest neighbour exchange S Groha, FHL Essler Journal of Physics A: Mathematical and Theoretical 50 (33), 334002, 2017 | 7 | 2017 |
| Trans-ethnic variation in germline variants of patients with renal cell carcinoma S Abou Alaiwi, AH Nassar, E Adib, SM Groha, EW Akl, BA McGregor, ... Cell Reports 34 (13), 108926, 2021 | 5 | 2021 |
| Constructing germline research cohorts from the discarded reads of clinical tumor sequences A Gusev, S Groha, K Taraszka, YR Semenov, N Zaitlen Genome medicine 13 (1), 1-14, 2021 | 4 | 2021 |
| Genetic determinants of chromatin reveal prostate cancer risk mediated by context-dependent gene regulation SC Baca, C Singler, S Zacharia, JH Seo, T Morova, F Hach, Y Ding, ... BioRxiv, 2021 | 4 | 2021 |
| Clinical Inflection Point Detection on the Basis of EHR Data to Identify Clinical Trial–Ready Patients With Cancer KL Kehl, S Groha, EM Lepisto, H Elmarakeby, J Lindsay, A Gusev, ... JCO Clinical Cancer Informatics 5, 622-630, 2021 | 1 | 2021 |
| Seeing beyond the target: leveraging off-target reads in targeted clinical tumor sequencing to identify prognostic biomarkers S Mangul, JJ Brito, S Groha, N Zaitlen, A Gusev bioRxiv, 2021 | 1 | 2021 |
| Topological Data Analysis of copy number alterations in cancer S Groha, C Weis, A Gusev, B Rieck arXiv preprint arXiv:2011.11070, 2020 | 1 | 2020 |
| Variation in targetable genomic alterations in non-small cell lung cancer by genetic ancestry, sex, smoking history, and histology E Adib, AH Nassar, S Abou Alaiwi, S Groha, EW Akl, LM Sholl, ... Genome medicine 14 (1), 1-10, 2022 | | 2022 |
| SurvLatent ODE: A Neural ODE based time-to-event model with competing risks for longitudinal data improves cancer-associated Deep Vein Thrombosis (DVT) prediction I Moon, S Groha, A Gusev arXiv preprint arXiv:2204.09633, 2022 | | 2022 |
| Genetic variation at IL7 provides mechanistic insights into toxicity to immune checkpoint blockade B Fairfax, C Taylor, R Watson, O Tong, W Ye, I Nassiri, J Gilchrist, ... | | 2022 |
| Germline variants associated with immunotherapy-related adverse events S Groha, S Abou Alaiwi, W Xu, V Naranbhai, AH Nassar, Z Bakouny, ... medRxiv, 2022 | | 2022 |
| Genetic ancestry and clinical outcomes to immune checkpoint inhibitors among seven common cancers. A Nassar, E Adib, S Abou Alaiwi, E Akl, T El Zarif, PV Nuzzo, ... Journal of Clinical Oncology 39 (15_suppl), 10536-10536, 2021 | | 2021 |
| Automated identification of immune related adverse events in oncology patients using machine learning. W Xu, A Gusev, S Groha, OE Rahma, D Schrag, TK Choueiri, KL Kehl Journal of Clinical Oncology 39 (15_suppl), 1551-1551, 2021 | | 2021 |
